Skip to main content
. 2022 Apr 6;10(4):565. doi: 10.3390/vaccines10040565

Figure 1.

Figure 1

(a): Anti-SARS-CoV-2 antibody after the second and the third dose of a SARS-CoV-2 mRNA vaccine among solid organ transplant recipients, depicted on a log-scale. Median after second dose: 7.1 (IQR 7.1–73.2); Median after third dose: 319.5 (IQR 17.2–1244.7). (b): Anti-SARS-CoV-2 antibody titers to SARS-CoV-2 vaccine correlated to transplant. Transplants: KTx (kidney), LiTx (liver), HTX (heart), LTx (lung), Multiple. From after the second dose to before third dose mean increase/decrease: −74.4 BAU/mL (95% CI: −208.9–60.2). From after the second dose to after the third dose mean increase/decrease: +831.2 BAU/mL (95% CI: 705.8–956.6).